Patents Represented by Attorney Charlene Launer
  • Patent number: 5616477
    Abstract: Novel fusion proteins that enhance the immune response of an antigen are efficiently expressed and secreted by yeast host cells. The fusion proteins are recombinantly made by fusing the 3'-end of mature GM-CSF DNA sequence to the 5'-end of an antigen DNA sequence with or without a linker sequence. Methods of expression in yeast cells are provided.
    Type: Grant
    Filed: May 2, 1996
    Date of Patent: April 1, 1997
    Assignee: Immunex Corporation
    Inventor: Virginia L. Price